한글목차

세계 기존 창상관리 시장 규모는 2025년 74억 2,000만 달러에서 예측 기간 동안 4.2%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 91억 2,000만 달러에 달할 것으로 예상됩니다.

이 시장의 성장은 당뇨병 유병률 증가, 외상 및 화상 사례 증가, 노인 인구 증가 등의 요인에 의해 주도되고 있습니다. 신흥국의 성장 잠재력과 기존 상처 치료 제품의 비용 효율성 또한 시장 성장의 기회로 작용하고 있습니다.

"최종 사용자별로는 재택치료 부문이 예측 기간 동안 가장 큰 규모를 나타낼 것으로 예상됩니다."

재택치료 부문은 2024년 가장 높은 시장 점유율을 보였습니다. 노인들은 당뇨병과 같은 만성 질환, 욕창 및 기타 부상으로 인해 상처 치료가 필요한 경우가 많습니다. 또한, 재택치료는 편리하고 저렴한 대안을 제공하여 비용이 많이 드는 입원의 필요성을 줄이고 환자와 의료 서비스 제공업체 모두 의료 비용을 절감할 수 있습니다. 많은 성인들이 병원이나 진료소가 아닌 집에서 편안함, 프라이버시, 편리함을 선호합니다. 드레싱 재료와 패스트에이드 등 다양한 유형의 기존 상처 관리 제품이 있기 때문에 의료진은 원격지에서도 효과적인 치료를 제공할 수 있습니다. 또한, 환자 치료에 대한 관심 증가와 맞춤 치료 계획에 대한 요구는 치료 결과 개선, 환자 만족도 향상, 보다 효율적인 의료 제공 모델을 제공하는 재택치료로의 전환에 기여하고 있습니다.

"용도별로는 급성 상처 부문이 가장 큰 시장 점유율을 보이고 있습니다."

급성 상처는 교통 사고 및 관련 부상 증가로 인해 2024년 가장 큰 시장 점유율을 차지했습니다. 급성 상처 치료는 상처, 찰과상, 찰과상, 찰과상, 화상 등의 상처를 치료하는 것으로 전통적인 상처 관리에서 중요한 역할을 합니다. 세척, 탈피, 적절한 드레싱 재료의 사용과 같은 방법은 치유를 촉진하고 감염의 위험을 줄입니다. 전통적인 치료는 멸균 드레싱과 수분 관리 등 상처 관리를 통해 조직 회복을 위한 최적의 환경을 조성하는 데 중점을 두고 있으며, 전통적인 방법은 급성 상처를 치료하고 회복을 촉진하는 데 있어 매우 중요합니다.

"아시아태평양이 가장 큰 성장세를 보일 것"

아시아태평양은 가장 빠르게 성장하고 있으며, 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다. 이는 이 지역 전체에서 당뇨병 유병률이 증가하고 있기 때문입니다. 이 지역에는 일본, 중국, 중국, 인도 및 기타 국가가 포함되며, 이 중 중국이 2024년 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 이는 제약 및 생명공학 산업의 급속한 성장과 더불어 환자 수가 많고 상처 치료에 대한 수요가 증가하고 있기 때문입니다. 중국에서는 의료 인프라가 잘 갖추어지고 있으며, 상처 치료에 대한 투자와 규제 환경이 개선되고 있습니다.

세계의 기존 창상관리(Wound Care) 시장을 조사했으며, 시장 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 기술 및 특허 동향, 법 및 규제 환경, 사례 분석, 시장 규모 추이 및 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 프리미엄 인사이트

제5장 시장 개요

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
  • 과제
• 가격 분석
• 밸류체인 분석
• 공급망 분석
• 생태계 분석
• Porter의 Five Forces 분석
• 규제 분석
• 무역 분석
• 특허 분석
• 2025-2026년 주요 컨퍼런스 및 이벤트
• 고객의 비즈니스에 영향을 미치는 동향/파괴적 변화
• 주요 이해관계자와 구입 기준
• AI/생성형 AI가 기존 창상관리 시장에 미치는 영향
• 투자 및 자금조달 시나리오
• 사례 연구 분석
• 기술 분석

제6장 기존 창상관리 시장 : 제품 유형별

• 고정 제품
  • 접착 테이프
  • 비접착 고정 제품
• 붕대
• 가제
  • 멸균 가제
  • 비멸균 가제
• 하이드로콜로이드 드레싱
• 구급 반창고
• 흡수 패드
• 압착 제품
  • 모든 압착 붕대
  • 압박 양말
• 드레싱재
  • 아일랜드 드레싱재
  • 필름 드레싱재
• 기타

제7장 기존 창상관리 시장 : 용도별

• 급성 창상
  • 외과적/외상성 창상
  • 화상
• 만성 창상
  • 당뇨병성 족궤양
  • 욕창
  • 정맥성 하지 궤양
  • 기타

제8장 기존 창상관리 시장 : 유통 채널별

• 의료기관
• 약국 및 드럭스토어
• 슈퍼마켓
• 홈케어
• 기타

제9장 기존 창상관리 시장 : 최종사용자별

• 병원 및 클리닉
  • 입원 환자
  • 외래 진료
• 재택 헬스케어
• 외래수술센터(ASC)
• 기타

제10장 기존 창상관리 시장 : 지역별

• 북미
  • 거시경제 전망
  • 미국
  • 캐나다
• 유럽
  • 거시경제 전망
  • 독일
  • 영국
  • 프랑스
  • 이탈리아
  • 스페인
  • 체코
  • 스위스
  • 폴란드
  • 오스트리아
  • 기타
• 아시아태평양
  • 거시경제 전망
  • 중국
  • 일본
  • 인도
  • 기타
• 라틴아메리카
  • 거시경제 전망
  • 브라질
  • 멕시코
  • 기타
• 중동 및 아프리카
  • 거시경제 전망

제11장 경쟁 구도

• 개요
• 주요 시장 진출기업의 전략/강점
• 매출 분석
• 시장 점유율 분석
• 기업 평가 매트릭스 : 주요 기업
• 기업 평가 매트릭스 : 스타트업/중소기업
• 기업 평가와 재무 지표
• 브랜드/제품 비교
• 경쟁 시나리오

제12장 기업 개요

• 주요 기업
  • SOLVENTUM
  • CARDINAL HEALTH
  • ESSITY AKTIEBOLAG
  • PAUL HARTMANN AG
  • MOLNLYCKE AB
  • BEIERSDORF
  • B. BRAUN SE
  • OWENS & MINOR, INC.
  • KENVUE
  • SMITH+NEPHEW
  • NITTO DENKO CORPORATION
  • MCKESSON CORPORATION
• 기타 기업
  • DYNAREX CORPORATION
  • MEDLINE INDUSTRIES, LP
  • LOHMANN & RAUSCHER GMBH & CO. KG
  • MEDICOM
  • WINNER MEDICAL CO., LTD.
  • VERNACARE LTD.
  • GF HEALTH PRODUCTS, INC.
  • DR. AUSBUTTEL & CO. GMBH
  • DERMARITE INDUSTRIES, LLC.
  • GENTELL
  • DEROYAL INDUSTRIES, INC.
  • URGO MEDICAL
  • DUKAL, LLC

제13장 부록

영문목차

The global Traditional wound care market is projected to reach USD 9.12 billion by 2030 from USD 7.42 billion in 2025, at a CAGR of 4.2% during the forecast period.

This is due to the increasing prevalence of diabetes, rising cases of traumatic injuries and burn injuries and growing elderly population drives market growth. Additionally, rising awareness about advanced wound care products is expected to impact market growth. Growth potential of emerging countries and cost effectiveness of traditional wound care products also poses an opportunistic factor for market growth. But is creating a conducive environment for market expansion over the forecast period of 2025-2030.

"The home healthcare segment of traditional wound cares market by end user to hold largest position forecast period."

Based on end user, the traditional wound care market is divided into hospitals & clinics, home healthcare, and ambulatory surgery centers. Among these, home healthcare hold the largest market share in 2024. The driving factor for the traditional wound care market is the aging population, as older population often require wound care due to chronic conditions like diabetes, pressure ulcers, or other injuries. Moreover, home healthcare offers a cheaper alternative at the patience convinence, reducing the need for over budget hospital stays and reducing healthcare expenses for both patients and healthcare providers. Many adults prefer the comfort, privacy, and ease of receiving care in their own homes instead of hospitals & clinics. Wide range of traditional wound care in wound care products, such as dressings and fast aids, make it easier for healthcare professionals to provide effective care remotely. Furthermore, the growing focus on patient care and the desire for personalized treatment plans contribute to the shift toward home healthcare, offering improved outcomes, better patient satisfaction, and a more efficient healthcare delivery model.

"The acute wound segment accounts for the largest market share in traditional wound cares market."

Based on application, the traditional wound care market is divided into chronic wounds and acute wounds. Among these, acute wounds hold the largest market share in 2024 due to their increased numbers of road accidents, as well as rise in related injuries. The acute wound care market has 2 segments surgical & traumatic wounds, and burns based for wound type. Both surgical and traumatic wounds needs proper assessment, timely intervention, infection prevention, and a tailored wound care plan to support optimal healing and minimize complications. Acute wound care plays an important role in traditional wound management by addressing injuries like cuts, abrasions, and burns. Methods such as cleaning, debridement, and the use of appropriate dressings promote healing and reduce infection risks. Traditional care focuses on creating an optimal environment for tissue repair, with wound management like sterile bandaging and moisture management. Traditional methods remain crucial for handeling acute wounds and fostering successful recovery.

"Asia Pacific is the fastest growing region of the traditional wound cares market by region."

The global traditional wound cares market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the fastest growing regional market for traditional wound care and is estimated to grow at the highest CAGR during the forecast period. This is due to increasing prevalence of diabetes across the region. Asia Pacific region includes Japan, China, India, and Rest of Asia Pacific. Among these, China accounts for the largest market share in traditional wound cares market in 2024. This is due to its rapid expansion of pharmaceutical and biotechnology industries, added with the with a large patient population and increasing demand for wound care treatments. The country's growing healthcare infrastructure, investment in wound care, and supportive regulatory environment.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-20%, Tier 2-45%, and Tier 3- 35%
• By Designation: C-level-30%, Director-level-20% and Others-50%
• By Region: North America-42%, Europe-32%, Asia Pacific-20%, Latin America- 4%, and Middle east and Africa - 2%

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the traditional wound cares market are Solventum (US), Cardinal Health (US), Smith+Nephew (UK), Nitto Denko Corporation (Japan), MCKESSON CORPORATION (US), Beiersdorf (Germany), Owens & Minor, Inc. (US), Essity Aktlebolag (Sweden), PAUL HARTMANN AG (Germany), Kenvue (US), Molnlycke AB (Sweden), and B. Braun SE (Germany).

Research Coverage

This report studies the traditional wound cares market based on product type, application, end user, distribution channel and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

• Analysis of Key divers (rising prevalence of diabetes, growing geriatric population, increasing incidence of burn injuries, rising cases of traumatic injuries, and rising expenditure on chronic wounds), restraints (risks associated with the use of traditional wound care products, and rising awareness about advanced wound care products), opportunity (Cost-effectiveness of traditional wound care products, and growth potential of emerging countries), Challenge (dearth of awareness)
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the traditional wound cares market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the traditional wound cares market
• Market Development: Comprehensive information on lucrative emerging regions
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the pain management devices market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
  • 1.2.1 INCLUSIONS & EXCLUSIONS
• 1.3 MARKET SCOPE
  • 1.3.1 MARKETS COVERED
  • 1.3.2 REGIONS COVERED
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Primary sources
    • 2.1.2.2 Key industry insights
    • 2.1.2.3 Key data from primary sources
    • 2.1.2.4 Breakdown of primary interviews
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.1.1 Approach 1: Company revenue estimation approach
    • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
    • 2.2.1.3 Approach 3: Primary interviews
    • 2.2.1.4 Growth forecast
    • 2.2.1.5 CAGR projections
  • 2.2.2 TOP-DOWN APPROACH
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
  • 2.4.1 STUDY-RELATED ASSUMPTIONS
  • 2.4.2 GROWTH RATE ASSUMPTIONS
• 2.5 RISK ASSESSMENT
• 2.6 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 TRADITIONAL WOUND CARE MARKET OVERVIEW
• 4.2 ASIA PACIFIC: TRADITIONAL WOUND CARE MARKET, BY END USER AND COUNTRY (2024)
• 4.3 GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.4 TRADITIONAL WOUND CARE MARKET, REGIONAL MIX, 2025 VS. 2030

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising prevalence of diabetes
    • 5.2.1.2 Growing geriatric population and subsequent rise in chronic wounds
    • 5.2.1.3 Increasing incidence of burn injuries
    • 5.2.1.4 Rising number of road accidents and trauma cases
    • 5.2.1.5 Increasing expenditure on chronic wounds
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 Limitations associated with traditional wound care
    • 5.2.2.2 Rising adoption of advanced wound care technologies
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Sustained adoption due to cost efficiency and wide accessibility
    • 5.2.3.2 Growth potential of emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Limited awareness associated with wound care
• 5.3 PRICING ANALYSIS
  • 5.3.1 INDICATIVE PRICE OF KEY PLAYERS, BY APPLICATION, 2025
  • 5.3.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION, 2023-2025
  • 5.3.3 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023-2025
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 SUPPLY CHAIN ANALYSIS
• 5.6 ECOSYSTEM ANALYSIS
• 5.7 PORTER'S FIVE FORCES ANALYSIS
  • 5.7.1 THREAT OF NEW ENTRANTS
  • 5.7.2 THREAT OF SUBSTITUTES
  • 5.7.3 BARGAINING POWER OF SUPPLIERS
  • 5.7.4 BARGAINING POWER OF BUYERS
  • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.8 REGULATORY ANALYSIS
  • 5.8.1 REGULATORY LANDSCAPE
    • 5.8.1.1 North America
      • 5.8.1.1.1 US
      • 5.8.1.1.2 Canada
    • 5.8.1.2 Europe
    • 5.8.1.3 Asia Pacific
      • 5.8.1.3.1 China
      • 5.8.1.3.2 Japan
      • 5.8.1.3.3 India
    • 5.8.1.4 Latin America
      • 5.8.1.4.1 Brazil
      • 5.8.1.4.2 Mexico
    • 5.8.1.5 Middle East & Africa
  • 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.9 TRADE ANALYSIS
  • 5.9.1 TRADE ANALYSIS FOR WADDING, GAUZE, AND BANDAGES
• 5.10 PATENT ANALYSIS
• 5.11 KEY CONFERENCES & EVENTS, 2025-2026
• 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.13 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.13.2 BUYING CRITERIA
• 5.14 IMPACT OF AI/GENERATIVE AI ON TRADITIONAL WOUND CARE MARKET
  • 5.14.1 INTRODUCTION
  • 5.14.2 MARKET POTENTIAL FOR TRADITIONAL WOUND CARE
  • 5.14.3 FUTURE OF GENERATIVE AI IN TRADITIONAL WOUND CARE
• 5.15 INVESTMENT & FUNDING SCENARIO
• 5.16 CASE STUDY ANALYSIS
  • 5.16.1 HYDROCOLL HYDROCOLLOID DRESSINGS TO SUPPORT RAPID WOUND HEALING
• 5.17 TECHNOLOGY ANALYSIS
  • 5.17.1 ADJACENT TECHNOLOGIES
    • 5.17.1.1 Negative pressure wound therapy
  • 5.17.2 COMPLEMENTARY TECHNOLOGIES
    • 5.17.2.1 Bioactive dressings

6 TRADITIONAL WOUND CARE MARKET, BY PRODUCT TYPE

• 6.1 INTRODUCTION
• 6.2 FIXATION PRODUCTS
  • 6.2.1 ADHESIVE TAPES
    • 6.2.1.1 Need for secure wound coverings and wound management to drive market
  • 6.2.2 NON-ADHESIVE FIXATION PRODUCTS
    • 6.2.2.1 Reduced swelling and minimized pain & trauma during dressing changes to support adoption
• 6.3 BANDAGES
  • 6.3.1 WIDE USAGE OF BANDAGES AND CONTINUED DEMAND TO SUPPORT MARKET GROWTH
• 6.4 GAUZE
  • 6.4.1 STERILE GAUZE
    • 6.4.1.1 Woven gauze
      • 6.4.1.1.1 Wide usage in surgeries and wound packing to propel market growth
    • 6.4.1.2 Non-woven gauze
      • 6.4.1.2.1 Enhanced absorption and wound coverage properties to drive usage
  • 6.4.2 NON-STERILE GAUZE
    • 6.4.2.1 Applications in cushioning, padding, and secondary dressing to support adoption
• 6.5 HYDROCOLLOID DRESSINGS
  • 6.5.1 MOISTURE REGULATION AND BENEFITS IN REMOVING NECROTIC TISSUE TO DRIVE MARKET
• 6.6 FIRST-AID PLASTERS
  • 6.6.1 NEED FOR RAPID WOUND MANAGEMENT AND PROTECTION TO PROPEL ADOPTION
• 6.7 ABSORBENT PADS
  • 6.7.1 WIDE USAGE IN WOUND DRESSING AND EXUDATE MANAGEMENT TO DRIVE MARKET
• 6.8 COMPRESSION PRODUCTS
  • 6.8.1 ALL COMPRESSION BANDAGES
    • 6.8.1.1 Ability to reduce swelling for rapid recovery to boost demand
  • 6.8.2 COMPRESSION SOCKS
    • 6.8.2.1 Prevention of venous disorders to support market growth
• 6.9 DRESSINGS
  • 6.9.1 ISLAND DRESSINGS
    • 6.9.1.1 Waterproof, antimicrobial, and absorbent properties to drive greater demand
  • 6.9.2 FILM DRESSINGS
    • 6.9.2.1 Secure adhesion and protection from bacteria & contaminants to support market growth
• 6.10 OTHER TRADITIONAL WOUND CARE PRODUCTS

7 TRADITIONAL WOUND CARE MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 ACUTE WOUNDS
  • 7.2.1 SURGICAL AND TRAUMATIC WOUNDS
    • 7.2.1.1 Rising volume of surgical procedures to drive market growth
  • 7.2.2 BURNS
    • 7.2.2.1 High incidence of burn injuries to drive the market growth
• 7.3 CHRONIC WOUNDS
  • 7.3.1 DIABETIC FOOT ULCERS
    • 7.3.1.1 Increasing prevalence of diabetes to propel market growth
  • 7.3.2 PRESSURE ULCERS
    • 7.3.2.1 Rising prevalence of pressure ulcers to sustain demand for wound care
  • 7.3.3 VENOUS LEG ULCERS
    • 7.3.3.1 Rising prevalence of obesity to drive market
  • 7.3.4 OTHER CHRONIC WOUNDS

8 TRADITIONAL WOUND CARE MARKET, BY DISTRIBUTION CHANNEL

• 8.1 INTRODUCTION
• 8.2 HEALTHCARE INSTITUTIONS
  • 8.2.1 RISING NUMBER OF TRAUMA CASES AND ROAD ACCIDENTS TO PROPEL MARKET
• 8.3 PHARMACIES & DRUG STORES
  • 8.3.1 PROVISION OF SPECIALIZED OTC PRODUCTS TO DRIVE MARKET
• 8.4 SUPERMARKETS
  • 8.4.1 WIDE ACCESSIBILITY TO NUMEROUS PRODUCTS TO FUEL MARKET
• 8.5 HOME CARE SETTINGS
  • 8.5.1 BENEFITS OF CONVENIENCE AND AFFORDABILITY TO BOOST DEMAND
• 8.6 OTHER DISTRIBUTION CHANNELS

9 TRADITIONAL WOUND CARE MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HOSPITALS & CLINICS
  • 9.2.1 INPATIENT SETTINGS
    • 9.2.1.1 Increasing hospital admissions due to HAIs to drive market
  • 9.2.2 OUTPATIENT SETTINGS
    • 9.2.2.1 Adoption of specialized wound care products to fuel market
• 9.3 HOME HEALTHCARE
  • 9.3.1 PROVISION OF ASSISTED LIVING AND SKILLED NURSING TO PROPEL MARKET
• 9.4 AMBULATORY SURGERY CENTERS
  • 9.4.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO DRIVE MARKET
• 9.5 OTHER END USERS

10 TRADITIONAL WOUND CARE MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 Rising prevalence of diabetes and favorable reimbursement policies to drive market
  • 10.2.3 CANADA
    • 10.2.3.1 Favorable government support for skin & wound care to support market growth
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 High prevalence of HAIs to propel market
  • 10.3.3 UK
    • 10.3.3.1 Increasing cases of burn injuries to support market adoption
  • 10.3.4 FRANCE
    • 10.3.4.1 High number of accidents to fuel market
  • 10.3.5 ITALY
    • 10.3.5.1 Growing accessibility to advanced medical care to boost demand
  • 10.3.6 SPAIN
    • 10.3.6.1 Rising geriatric population and subsequent increase in injuries to support market adoption
  • 10.3.7 CZECH REPUBLIC
    • 10.3.7.1 Rising incidence of diabetes to fuel uptake
  • 10.3.8 SWITZERLAND
    • 10.3.8.1 Rising incidence of chronic diseases to boost demand
  • 10.3.9 POLAND
    • 10.3.9.1 Improvements in healthcare infrastructure to favor market growth
  • 10.3.10 AUSTRIA
    • 10.3.10.1 Increasing initiatives to spread awareness of effective wound care to boost demand
  • 10.3.11 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 Increasing incidence of diabetic foot ulcers among geriatric population to drive market
  • 10.4.3 JAPAN
    • 10.4.3.1 Presence of well-developed healthcare system and favorable government policies to favor market growth
  • 10.4.4 INDIA
    • 10.4.4.1 Growing medical tourism and increasing diabetes population to support market growth
  • 10.4.5 REST OF ASIA PACIFIC
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Increased healthcare expenditure and need for wound management for athletes to drive market
  • 10.5.3 MEXICO
    • 10.5.3.1 Increasing traffic fatalities and injuries to boost market growth
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 RISING GERIATRIC POPULATION AND GROWING PREVALENCE OF DIABETES TO BOOST MARKET
  • 10.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN TRADITIONAL WOUND CARE MARKET
• 11.3 REVENUE ANALYSIS, 2022-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
  • 11.4.1 RANKING OF KEY MARKET PLAYERS
• 11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.5.1 STARS
  • 11.5.2 EMERGING LEADERS
  • 11.5.3 PERVASIVE PLAYERS
  • 11.5.4 PARTICIPANTS
  • 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.5.5.1 Company footprint
    • 11.5.5.2 Region footprint
    • 11.5.5.3 Product footprint
    • 11.5.5.4 Application footprint
    • 11.5.5.5 Fixation products footprint
• 11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.6.1 PROGRESSIVE COMPANIES
  • 11.6.2 RESPONSIVE COMPANIES
  • 11.6.3 DYNAMIC COMPANIES
  • 11.6.4 STARTING BLOCKS
  • 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.6.5.1 Detailed list of key startups/SMEs
    • 11.6.5.2 Competitive benchmarking of key startups/SMEs
• 11.7 COMPANY VALUATION & FINANCIAL METRICS
  • 11.7.1 COMPANY VALUATION
  • 11.7.2 FINANCIAL METRICS
• 11.8 BRAND/PRODUCT COMPARISON
• 11.9 COMPETITIVE SCENARIO
  • 11.9.1 PRODUCT LAUNCHES
  • 11.9.2 DEALS
  • 11.9.3 EXPANSIONS
  • 11.9.4 OTHER DEVELOPMENTS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 SOLVENTUM
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Other developments
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Key strengths
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 CARDINAL HEALTH
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Deals
      • 12.1.2.3.2 Expansions
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Key strengths
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 ESSITY AKTIEBOLAG
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Expansions
      • 12.1.3.3.2 Other developments
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Key strengths
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 PAUL HARTMANN AG
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Deals
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Key strengths
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 MOLNLYCKE AB
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Key strengths
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 BEIERSDORF
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
    • 12.1.6.3 Recent developments
      • 12.1.6.3.1 Product launches
      • 12.1.6.3.2 Deals
      • 12.1.6.3.3 Expansions
  • 12.1.7 B. BRAUN SE
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
    • 12.1.7.3 Recent developments
      • 12.1.7.3.1 Deals
      • 12.1.7.3.2 Expansions
  • 12.1.8 OWENS & MINOR, INC.
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
    • 12.1.8.3 Recent developments
      • 12.1.8.3.1 Deals
  • 12.1.9 KENVUE
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
  • 12.1.10 SMITH+NEPHEW
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Deals
  • 12.1.11 NITTO DENKO CORPORATION
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
    • 12.1.11.3 Recent developments
      • 12.1.11.3.1 Deals
  • 12.1.12 MCKESSON CORPORATION
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Deals
• 12.2 OTHER PLAYERS
  • 12.2.1 DYNAREX CORPORATION
  • 12.2.2 MEDLINE INDUSTRIES, LP
  • 12.2.3 LOHMANN & RAUSCHER GMBH & CO. KG
  • 12.2.4 MEDICOM
  • 12.2.5 WINNER MEDICAL CO., LTD.
  • 12.2.6 VERNACARE LTD.
  • 12.2.7 GF HEALTH PRODUCTS, INC.
  • 12.2.8 DR. AUSBUTTEL & CO. GMBH
  • 12.2.9 DERMARITE INDUSTRIES, LLC.
  • 12.2.10 GENTELL
  • 12.2.11 DEROYAL INDUSTRIES, INC.
  • 12.2.12 URGO MEDICAL
  • 12.2.13 DUKAL, LLC

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS